Is Cerebrolysin FDA approved?

Cerebrolysin is investigational and not FDA approved. It is discussed for research and educational purposes only, not as medical guidance.

Is Dalargin FDA approved?

Dalargin is not evaluated or approved by the FDA. It is discussed for research and educational purposes only, not as medical guidance.

How is Cerebrolysin administered in research settings?

In research settings, Cerebrolysin is typically administered via the intravenous or intramuscular routes. PeptideBase does not provide dosing or administration instructions.

How is Dalargin administered in research settings?

In research settings, Dalargin is typically administered via the subcutaneous or intravenous routes. PeptideBase does not provide dosing or administration instructions.

Home›Research›Compare›Cerebrolysin vs Dalargin

Peptide Comparison

Cerebrolysin vs Dalargin

Name: Cerebrolysin vs Dalargin — Per-mg Price Comparison
Creator: PeptideBase
License: https://peptidebase.io/terms

Both are Neuro & Cognitive peptides.

Cerebrolysin

FPF 1070

CognitiveInvestigationalResearch Only

Half-life: Varies by component

33 providers listed

Full Cerebrolysin profile →

Dalargin

Leu-enkephalin-Arg

RecoveryNot EvaluatedResearch Only

No providers listed yet

Full Dalargin profile →

Bottom line

Cerebrolysin carries stronger published evidence (Meta-analysis, 5 key studies) than Dalargin (Animal, 1); both are research compounds.

Quick Verdict

Cerebrolysin

Dalargin

Which One Should You Choose?

Your goal	Better option
Stronger clinical evidence	Cerebrolysin
Further along in FDA review	Cerebrolysin
More provider options (33 vs 0)	Cerebrolysin

Research summary only — not medical advice. Consult a qualified provider before making any decisions.

Side-by-Side Comparison

Cerebrolysin

Dalargin

Mechanism Family

Neuro & Cognitive

Half-life

Varies by component

—

FDA Status

investigational

not evaluated

Admin Routes

intravenous, intramuscular

subcutaneous, intravenous

Availability

Research Only

Providers

33 listed

None listed

Avail. Notes

Neuropeptide mixture approved in EU/Asia but NOT FDA-approved. Phase 2/3 US trials for Alzheimer's disease and stroke with active IND. No NDA filed. Research use in US.

—

Research Evidence

Cerebrolysin

Meta-analysis · 5 key studies · most recent 2026

Dalargin

Animal · 1 key study · dated evidence base — most recent 2009

Research Citations

Cerebrolysin

Meta-analysis2019 · Cochrane Database of Systematic Reviews

Cerebrolysin for vascular dementia

Cohort2026 · Asian J Neurosurg

Neuroprotective Effects of Cerebrolysin in Moderate Traumatic Brain Injury with Nonoperative Lesions: A 6-Mon…

RCT2024 · Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Cerebrolysin in the preventive therapy of dementia in elderly patients with mild cognitive impairment: a thre…

In vitro2026 · Cells

Exosomes Released by Cerebrolysin-Treated Cerebral Endothelial Cells Reverse Fibrin- or tPA-Impaired Endothel…

+1 more

Dalargin

Animal2009 · Bulletin of Experimental Biology and Medicine

Gastroprotective effect of dalargin in gastropathy due to treatment with nonsteroid antiinflammatory drugs

About Cerebrolysin

Standardized mixture of neuropeptides derived from porcine brain proteins; mimics endogenous neurotrophic factors (BDNF, NGF, CNTF); promotes neurogenesis and synaptic plasticity

Research Areas

neuroprotectionneuroplasticitymemory improvementcognitive recovery

About Dalargin

Binds delta and mu opioid receptors with peripheral preference due to limited CNS penetration. Reduces gastric acid secretion, promotes mucosal blood flow, and inhibits ulcer formation via prostaglandin-mediated pathways.

Research Areas

gastroprotectionGI repairanti-ulcerpain modulation

Safety Profile

Information below reflects published research data only — not medical advice. Consult a qualified provider before use.

Cerebrolysin

Reported (Unverified — Pending Clinical Review)

epilepsyrenal failureporcine protein allergy

No established clinical contraindications

Dalargin

No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.

Price (per mg)

Cerebrolysin

$0.83/mg

$0.82 – $0.83 range

9 vendors

View price index →Find providers →

Dalargin

Not enough vendor pricing yet.

Find Providers

Where to source these peptides

Providers offering

Cerebrolysin

33 listed

Browse directory →

Providers offering

Dalargin

Browse directory →

PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.

More Neuro & Cognitive Comparisons

Browse all peptides →

Educational research tools — not medical advice.

Cite this page

Data last updated August 26, 2026

Free to reference and republish with attribution to PeptideBase. Choose a format:

PeptideBase. (2026). Cerebrolysin vs Dalargin — Per-mg Price Comparison. Retrieved September 11, 2026, from https://peptidebase.io/peptides/compare/cerebrolysin/dalargin

https://peptidebase.io/peptides/compare/cerebrolysin/dalargin Methodology License Download JSON Download CSV